Leerink Partnrs Issues Pessimistic Outlook for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Equities research analysts at Leerink Partnrs cut their Q2 2025 earnings estimates for Ardent Health Partners in a note issued to investors on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $0.59 for the quarter, down from their previous forecast of $0.61. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners' Q1 2026 earnings at $0.44 EPS, Q3 2026 earnings at $0.52 EPS and FY2028 earnings at $2.88 EPS.

Other analysts also recently issued reports about the company. Guggenheim raised their price target on Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Friday. Stephens reiterated an "overweight" rating and set a $22.00 price objective on shares of Ardent Health Partners in a report on Tuesday, April 1st. Mizuho reduced their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Royal Bank of Canada reduced their price objective on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Tuesday, March 4th. Finally, Morgan Stanley dropped their price target on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Ardent Health Partners presently has a consensus rating of "Buy" and an average price target of $20.75.

Ardent Health Partners Trading Down 2.0%

Shares of NYSE:ARDT traded down $0.29 during trading on Monday, hitting $14.54. The company had a trading volume of 247,885 shares, compared to its average volume of 397,011. The stock has a market cap of $2.08 billion and a price-to-earnings ratio of 8.92. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company has a fifty day simple moving average of $13.08 and a two-hundred day simple moving average of $14.90. Ardent Health Partners has a one year low of $11.31 and a one year high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion.

Hedge Funds Weigh In On Ardent Health Partners

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Ardent Health Partners in the 4th quarter valued at about $27,000. US Bancorp DE acquired a new stake in Ardent Health Partners in the fourth quarter valued at approximately $31,000. R Squared Ltd acquired a new stake in Ardent Health Partners in the fourth quarter valued at approximately $37,000. Morse Asset Management Inc purchased a new position in Ardent Health Partners in the first quarter worth $36,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Ardent Health Partners during the fourth quarter worth $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.